Cajal Neuroscience

Neurodegenerative Therapies

Undisclosed RD Parkinson's disease

Cajal Neuroscience is developing drugs for neurodegenerative diseases. The complexity of the brain was uncovered by pioneering research by Santiago Ramón y Cajal, who illustrated his findings with hundreds of drawings. Inspired by his creativity, Cajal Neuroscience is researching how to model and treat complex diseases of the brain. By using a combination of high throughput microscopy, functional genetic screening and multi-omics approaches, Cajal can identify new drug targets for neurodegenerative diseases. To achieve success, Cajal will employ expertise from neurosurgeons, scientists and software engineers to generate and analyze high quality data.